Dissecting the role of aberrant DNA methylation in human leukemia
View/ Open
Author
Amabile, Giovanni
Di Ruscio, Annalisa
Müller, Fabian
Yang, Henry
Zhang, Hong
Qi, Lihua
Martinelli, Giovanni
Brummelkamp, Thijn
Le Beau, Michelle M
Figueroa, Maria E
Bock, Christoph
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/ncomms8091Metadata
Show full item recordCitation
Amabile, G., A. Di Ruscio, F. Müller, R. S. Welner, H. Yang, A. K. Ebralidze, H. Zhang, et al. 2015. “Dissecting the role of aberrant DNA methylation in human leukemia.” Nature communications 6 (1): 7091. doi:10.1038/ncomms8091. http://dx.doi.org/10.1038/ncomms8091.Abstract
Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder characterized by the genetic translocation t(9;22)(q34;q11.2) encoding for the BCR-ABL fusion oncogene. However, many molecular mechanisms of the disease progression still remain poorly understood. A growing body of evidence suggests that epigenetic abnormalities are involved in tyrosine kinase resistance in CML, leading to leukemic clone escape and disease propagation. Here we show that, by applying cellular reprogramming to primary CML cells, aberrant DNA methylation contributes to the disease evolution. Importantly, using a BCR-ABL inducible murine model, we demonstrate that a single oncogenic lesion triggers DNA methylation changes which in turn act as a precipitating event in leukemia progression.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443494/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:23845161
Collections
- HMS Scholarly Articles [17918]
Contact administrator regarding this item (to report mistakes or request changes)